Abstract
Purpose: To employ four-dimensional (4D) flow MRI to investigate associations between hemodynamic parameters with systolic anterior motion (SAM), mitral regurgitation (MR), stroke volume, and cardiac mass in patients with hypertrophic cardiomyopathy (HCM). Materials and Methods: A total of 13 patients with HCM (51 years ± 16 [standard deviation]; 10 men) and 11 age-matched healthy control subjects (54 years ± 15; eight men) underwent cardiac 4D flow MRI data analysis including calculation of peak systolic and diastolic control-averaged left ventricular (LV) velocity maps to quantify volumes of elevated velocity (EVV) in the left ventricle. Standardof-care cine imaging was performed in short-axis, LV outflow tract (LVOT), and two-, three-, and four-chamber views on which the presence of SAM, presence of MR, total stroke volume, and cardiac mass were assessed. Results: Systolic EVV in patients with HCM was 7 mL ± 5, which was significantly associated with elevated aortic peak velocity (R = 0.87; P < .001), decreased LVOT diameter (R = 0.68; P = .01), and increased cardiac mass (R = 0.62; P = .02). In addition, EVV differed significantly between patients with and those without SAM (10 mL ± 4.7 vs 3 mL ± 2.3; P = .03) and those with and those without MR (9.9 mL ± 4.8 vs 4.0 mL ± 3.2; P < .05). In the atrial systolic phase, peak diastolic velocity in the LV correlated with septal thickness (R = 0.66; P = .01). Conclusion: Quantification and visualization of EVV in the LV is feasible and may provide further insight into the clinical manifestations of altered hemodynamics in HCM.
Original language | English (US) |
---|---|
Article number | e190038 |
Journal | Radiology: Cardiothoracic Imaging |
Volume | 2 |
Issue number | 1 |
DOIs | |
State | Published - Feb 2020 |
Funding
B.D.A. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: consultant for Tempus; received grant funding from RSNA Resident Research Grant. Other relationships: disclosed no relevant relationships. A.J.B. disclosed no relevant relationships. R.O.B. Activities related to the present article: received grant funding from the National Institutes of Health. Activities not related to the present article: disclosed no relevant relationships. Other relationships: disclosed no relevant relationships. L.C. disclosed no relevant relationships. J.C.C. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: consultant for Siemens, GE, Circle, Bayer, and Guerbet; received grant funding through Guerbet, Bayer, and Siemens; received payments for lectures from Circle, Guerbet, and Bayer.
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging